Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Pancreatic Adenocarcinoma, Version 1.2019.

Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK, Fountzilas C, Wolpin BM, Al-Hawary M, Asbun H, Behrman SW, Benson AB, Binder E, Cardin DB, Cha C, Chung V, Dillhoff M, Dotan E, Ferrone CR, Fisher G, Hardacre J, Hawkins WG, Ko AH, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Thayer S, Wolff RA, Burns JL, Zuccarino-Catania G.

J Natl Compr Canc Netw. 2019 Mar 1;17(3):202-210. doi: 10.6004/jnccn.2019.0014.

PMID:
30865919
2.

Role of pelvic chemoradiation therapy in patients with initially metastatic anal canal cancer: A National Cancer Data Base review.

Abdelazim YA, Rushing CN, Palta M, Willett CG, Czito BG.

Cancer. 2019 Mar 2. doi: 10.1002/cncr.32017. [Epub ahead of print]

PMID:
30825391
3.

Low- vs. High-Dose Neoadjuvant Radiation in Trimodality Treatment of Locally Advanced Esophageal Cancer.

Ji KSY, Thomas SM, Roman SA, Czito B, Anderson KL Jr, Frakes J, Adam MA, Sosa JA, Robinson TJ.

J Gastrointest Surg. 2018 Oct 29. doi: 10.1007/s11605-018-4007-3. [Epub ahead of print]

PMID:
30374818
4.

Intratreatment Response Assessment With 18F-FDG PET: Correlation of Semiquantitative PET Features With Pathologic Response of Esophageal Cancer to Neoadjuvant Chemoradiotherapy.

Tandberg DJ, Cui Y, Rushing CN, Hong JC, Ackerson BG, Marin D, Zhang X, Czito BG, Willett CW, Palta M.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1002-1007. doi: 10.1016/j.ijrobp.2018.07.187. Epub 2018 Jul 25.

PMID:
30055238
5.

Association of Interim FDG-PET Imaging During Chemoradiation for Squamous Anal Canal Carcinoma With Recurrence.

Hong JC, Cui Y, Patel BN, Rushing CN, Faught AM, Eng JS, Higgins K, Yin FF, Das S, Czito BG, Willett CG, Palta M.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1046-1051. doi: 10.1016/j.ijrobp.2018.04.062. Epub 2018 May 4.

PMID:
29891206
6.

The role of external beam radiotherapy in the treatment of hepatocellular cancer.

Chino F, Stephens SJ, Choi SS, Marin D, Kim CY, Morse MA, Godfrey DJ, Czito BG, Willett CG, Palta M.

Cancer. 2018 Sep 1;124(17):3476-3489. doi: 10.1002/cncr.31334. Epub 2018 Apr 12. Review.

PMID:
29645076
7.

The Selective Use of Radiation Therapy in Rectal Cancer Patients.

Martella A, Willett C, Palta M, Czito B.

Curr Oncol Rep. 2018 Apr 11;20(6):43. doi: 10.1007/s11912-018-0689-7. Review.

PMID:
29644477
8.

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, Benson AB 3rd, Binder E, Cardin DB, Cha C, Chiorean EG, Chung V, Czito B, Dillhoff M, Dotan E, Ferrone CR, Hardacre J, Hawkins WG, Herman J, Ko AH, Komanduri S, Koong A, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Scaife C, Thayer S, Weekes CD, Wolff RA, Wolpin BM, Burns J, Darlow S.

J Natl Compr Canc Netw. 2017 Aug;15(8):1028-1061. doi: 10.6004/jnccn.2017.0131.

PMID:
28784865
9.

Retrospective four-dimensional magnetic resonance imaging with image-based respiratory surrogate: a sagittal-coronal-diaphragm point of intersection motion tracking method.

Liu Y, Yin FF, Czito BG, Bashir MR, Palta M, Cai J.

J Med Imaging (Bellingham). 2017 Apr;4(2):024007. doi: 10.1117/1.JMI.4.2.024007. Epub 2017 Jun 19.

10.

Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study.

Czito BG, Deming DA, Jameson GS, Mulcahy MF, Vaghefi H, Dudley MW, Holen KD, DeLuca A, Mittapalli RK, Munasinghe W, He L, Zalcberg JR, Ngan SY, Komarnitsky P, Michael M.

Lancet Gastroenterol Hepatol. 2017 Jun;2(6):418-426. doi: 10.1016/S2468-1253(17)30012-2. Epub 2017 Mar 27.

PMID:
28497757
11.

Total neoadjuvant therapy for rectal cancer: An emerging option.

Ludmir EB, Palta M, Willett CG, Czito BG.

Cancer. 2017 May 1;123(9):1497-1506. doi: 10.1002/cncr.30600. Epub 2017 Mar 10. Review.

12.

Association Between Incomplete Neoadjuvant Radiotherapy and Survival for Patients With Locally Advanced Rectal Cancer.

Freischlag K, Sun Z, Adam MA, Kim J, Palta M, Czito BG, Migaly J, Mantyh CR.

JAMA Surg. 2017 Jun 1;152(6):558-564. doi: 10.1001/jamasurg.2017.0010.

13.

Four-dimensional diffusion-weighted MR imaging (4D-DWI): a feasibility study.

Liu Y, Zhong X, Czito BG, Palta M, Bashir MR, Dale BM, Yin FF, Cai J.

Med Phys. 2017 Feb;44(2):397-406. doi: 10.1002/mp.12037. Epub 2017 Jan 25.

14.

Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.

Mowery YM, Salama JK, Zafar SY, Moore HG, Willett CG, Czito BG, Hopkins MB, Palta M.

Cancer. 2017 Apr 15;123(8):1434-1441. doi: 10.1002/cncr.30461. Epub 2016 Dec 16.

15.

Evolution and Management of Treatment-Related Toxicity in Anal Cancer.

Ludmir EB, Kachnic LA, Czito BG.

Surg Oncol Clin N Am. 2017 Jan;26(1):91-113. doi: 10.1016/j.soc.2016.07.004. Review.

PMID:
27889040
16.

A current perspective on stereotactic body radiation therapy for pancreatic cancer.

Hong JC, Czito BG, Willett CG, Palta M.

Onco Targets Ther. 2016 Oct 31;9:6733-6739. eCollection 2016. Review.

17.

Radiation Therapy for Soft Tissue Sarcoma: Indications and Controversies for Neoadjuvant Therapy, Adjuvant Therapy, Intraoperative Radiation Therapy, and Brachytherapy.

Larrier NA, Czito BG, Kirsch DG.

Surg Oncol Clin N Am. 2016 Oct;25(4):841-60. doi: 10.1016/j.soc.2016.05.012. Epub 2016 Aug 6. Review.

PMID:
27591502
18.

Intensity-Modulated Radiation Therapy Is Not Associated with Perioperative or Survival Benefit over 3D-Conformal Radiotherapy for Rectal Cancer.

Sun Z, Adam MA, Kim J, Czito B, Mantyh C, Migaly J.

J Gastrointest Surg. 2017 Jan;21(1):106-111. doi: 10.1007/s11605-016-3242-8. Epub 2016 Aug 10.

PMID:
27510332
19.

The Use of Re-irradiation in Locally Recurrent, Non-metastatic Rectal Cancer.

Susko M, Lee J, Salama J, Thomas S, Uronis H, Hsu D, Migaly J, Willett C, Czito B, Palta M.

Ann Surg Oncol. 2016 Oct;23(11):3609-3615. doi: 10.1245/s10434-016-5250-z. Epub 2016 May 11.

PMID:
27169769
20.

Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the RAND/UCLA Appropriateness Method.

Goodman KA, Patton CE, Fisher GA, Hoffe SE, Haddock MG, Parikh PJ, Kim J, Baxter NN, Czito BG, Hong TS, Herman JM, Crane CH, Hoffman KE.

Pract Radiat Oncol. 2016 May-Jun;6(3):166-175. doi: 10.1016/j.prro.2015.11.014. Epub 2015 Nov 24.

PMID:
26922700
21.

Nonoperative management of rectal cancer.

Torok JA, Palta M, Willett CG, Czito BG.

Cancer. 2016 Jan 1;122(1):34-41. doi: 10.1002/cncr.29735. Epub 2015 Nov 24. Review.

22.

Role of Adjuvant Radiotherapy in Locally Advanced Colonic Carcinoma in the Modern Chemotherapy Era.

Ludmir EB, Arya R, Wu Y, Palta M, Willett CG, Czito BG.

Ann Surg Oncol. 2016 Mar;23(3):856-62. doi: 10.1245/s10434-015-4907-3. Epub 2015 Oct 19.

PMID:
26480849
23.

Adjuvant radiation therapy for pancreatic cancer: a review of the old and the new.

Boyle J, Czito B, Willett C, Palta M.

J Gastrointest Oncol. 2015 Aug;6(4):436-44. doi: 10.3978/j.issn.2078-6891.2015.014. Review.

24.

Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma.

Lane WO, Cramer CK, Nussbaum DP, Speicher PJ, Gulack BC, Czito BG, Kirsch DG, Tyler DS, Blazer DG 3rd.

J Surg Oncol. 2015 Sep;112(4):352-8. doi: 10.1002/jso.23996. Epub 2015 Aug 4.

PMID:
26238282
25.

T2-weighted four dimensional magnetic resonance imaging with result-driven phase sorting.

Liu Y, Yin FF, Czito BG, Bashir MR, Cai J.

Med Phys. 2015 Aug;42(8):4460-71. doi: 10.1118/1.4923168.

26.

Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience.

Wang J, Narang AK, Sugar EA, Luber B, Rosati LM, Hsu CC, Fuller CD, Pawlik TM, Miller RC, Czito BG, Tuli R, Crane CH, Ben-Josef E, Thomas CR Jr, Herman JM.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1100-6. doi: 10.1245/s10434-015-4685-y. Epub 2015 Jul 30.

PMID:
26224402
27.

Neoadjuvant radiation therapy does not increase perioperative morbidity among patients undergoing gastrectomy for gastric cancer.

Sun Z, Nussbaum DP, Speicher PJ, Czito BG, Tyler DS, Blazer DG 3rd.

J Surg Oncol. 2015 Jul;112(1):46-50. doi: 10.1002/jso.23957. Epub 2015 Jul 14.

PMID:
26179329
28.

Human papillomavirus tumor infection in esophageal squamous cell carcinoma.

Ludmir EB, Stephens SJ, Palta M, Willett CG, Czito BG.

J Gastrointest Oncol. 2015 Jun;6(3):287-95. doi: 10.3978/j.issn.2078-6891.2015.001. Review.

29.

Patterns of failure for stage I ampulla of Vater adenocarcinoma: a single institutional experience.

Zhong J, Palta M, Willett CG, McCall SJ, McSherry F, Tyler DS, Uronis HE, Czito BG.

J Gastrointest Oncol. 2014 Dec;5(6):421-7. doi: 10.3978/j.issn.2078-6891.2014.084.

30.

Incidence and prognostic impact of high-risk HPV tumor infection in cervical esophageal carcinoma.

Ludmir EB, Palta M, Zhang X, Wu Y, Willett CG, Czito BG.

J Gastrointest Oncol. 2014 Dec;5(6):401-7. doi: 10.3978/j.issn.2078-6891.2014.053.

31.

Intraoperative radiotherapy for gastrointestinal malignancies: contemporary outcomes with multimodality therapy.

Calvo FA, Sole CV, Marsiglia H, Alvarado E, Ferrer C, Czito B.

Curr Oncol Rep. 2015 Jan;17(1):419. doi: 10.1007/s11912-014-0419-8.

PMID:
25416313
32.

Investigation of sagittal image acquisition for 4D-MRI with body area as respiratory surrogate.

Liu Y, Yin FF, Chang Z, Czito BG, Palta M, Bashir MR, Qin Y, Cai J.

Med Phys. 2014 Oct;41(10):101902. doi: 10.1118/1.4894726.

33.

Radiosensitive orbital metastasis as presentation of occult colonic adenocarcinoma.

Ludmir EB, McCall SJ, Czito BG, Palta M.

BMJ Case Rep. 2014 Sep 19;2014. pii: bcr2014206407. doi: 10.1136/bcr-2014-206407.

34.

Is diaphragm motion a good surrogate for liver tumor motion?

Yang J, Cai J, Wang H, Chang Z, Czito BG, Bashir MR, Palta M, Yin FF.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):952-8. doi: 10.1016/j.ijrobp.2014.07.028. Epub 2014 Sep 12.

35.

Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.

Tempero MA, Malafa MP, Behrman SW, Benson AB 3rd, Casper ES, Chiorean EG, Chung V, Cohen SJ, Czito B, Engebretson A, Feng M, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Lowy AM, Ma WW, Merchant NB, Mulvihill SJ, Muscarella P 2nd, Nakakura EK, Obando J, Pitman MB, Reddy S, Sasson AR, Thayer SP, Weekes CD, Wolff RA, Wolpin BM, Burns JL, Freedman-Cass DA.

J Natl Compr Canc Netw. 2014 Aug;12(8):1083-93.

PMID:
25099441
36.

Results of the FFCD 9901 trial in early-stage esophageal carcinoma: is it really about neoadjuvant therapy?

Czito BG, Palta M, Willett CG.

J Clin Oncol. 2014 Aug 10;32(23):2398-400. doi: 10.1200/JCO.2014.55.7231. Epub 2014 Jun 30. No abstract available.

PMID:
24982460
37.

Short-course versus long-course chemoradiation in rectal cancer--time to change strategies?

Palta M, Willett CG, Czito BG.

Curr Treat Options Oncol. 2014 Sep;15(3):421-8. doi: 10.1007/s11864-014-0296-2. Review.

PMID:
24915746
38.

Patterns of recurrence after trimodality therapy for esophageal cancer.

Dorth JA, Pura JA, Palta M, Willett CG, Uronis HE, D'Amico TA, Czito BG.

Cancer. 2014 Jul 15;120(14):2099-105. doi: 10.1002/cncr.28703. Epub 2014 Apr 7.

39.

Colorectal cancer: adjuvant chemotherapy for rectal cancer-an unresolved issue.

Palta M, Czito BG, Willett CG.

Nat Rev Clin Oncol. 2014 Apr;11(4):182-4. doi: 10.1038/nrclinonc.2014.43. Epub 2014 Mar 18. No abstract available.

PMID:
24642673
40.

The role of intraoperative radiation therapy in patients with pancreatic cancer.

Palta M, Willett C, Czito B.

Semin Radiat Oncol. 2014 Apr;24(2):126-31. doi: 10.1016/j.semradonc.2013.11.004. Review.

PMID:
24635869
41.

Four-dimensional magnetic resonance imaging using axial body area as respiratory surrogate: initial patient results.

Yang J, Cai J, Wang H, Chang Z, Czito BG, Bashir MR, Yin FF.

Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):907-12. doi: 10.1016/j.ijrobp.2013.11.245. Epub 2014 Jan 17.

42.

Oncology scan--gastrointestinal cancers.

Willett CG, Chang D, Czito B, Meyer J, Wo J.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):861-3. doi: 10.1016/j.ijrobp.2013.09.006. No abstract available.

PMID:
24267962
43.

Radiation therapy in anal and rectal cancer.

Czito BG, Meyer J.

Surg Oncol Clin N Am. 2013 Jul;22(3):525-43. doi: 10.1016/j.soc.2013.02.010. Epub 2013 Mar 19. Review.

PMID:
23622078
44.

ACT II: treatment of anal cancer comes full circle.

Willett CG, Czito BG, Palta M.

Lancet Oncol. 2013 May;14(6):443-5. doi: 10.1016/S1470-2045(13)70121-9. Epub 2013 Apr 9. No abstract available.

PMID:
23578723
45.

The role of local excision in invasive adenocarcinoma of the ampulla of Vater.

Zhong J, Palta M, Willett CG, McCall SJ, Bulusu A, Tyler DS, White RR, Uronis HE, Pappas TN, Czito BG.

J Gastrointest Oncol. 2013 Mar;4(1):8-13. doi: 10.3978/j.issn.2078-6891.2012.055.

46.

Preoperative chemoradiotherapy for locally advanced gastric cancer.

Pepek JM, Chino JP, Willett CG, Palta M, Blazer Iii DG, Tyler DS, Uronis HE, Czito BG.

Radiat Oncol. 2013 Jan 4;8:6. doi: 10.1186/1748-717X-8-6.

47.

Technical considerations in radiation therapy for gastroesophageal junction cancer.

Pepek JM, Willett CG, Czito BG.

Semin Radiat Oncol. 2013 Jan;23(1):51-9. doi: 10.1016/j.semradonc.2012.09.005. Review.

PMID:
23207047
48.

Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.

Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB 3rd, Casper ES, Cohen SJ, Czito B, Ellenhorn JD, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Ma WW, Malafa MP, Merchant NB, Mulvihill SJ, Muscarella P 2nd, Nakakura EK, Obando J, Pitman MB, Sasson AR, Tally A, Thayer SP, Whiting S, Wolff RA, Wolpin BM, Freedman-Cass DA, Shead DA; National Comprehensive Cancer Networks.

J Natl Compr Canc Netw. 2012 Jun 1;10(6):703-13.

49.

IMRT treatment of anal cancer with a scrotal shield.

Hood RC, Wu QJ, McMahon R, Czito B, Willett C.

Med Dosim. 2012 Winter;37(4):432-5. doi: 10.1016/j.meddos.2012.03.007. Epub 2012 Apr 25.

PMID:
22538113
50.

Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?

Papalezova KT, Tyler DS, Blazer DG 3rd, Clary BM, Czito BG, Hurwitz HI, Uronis HE, Pappas TN, Willett CG, White RR.

J Surg Oncol. 2012 Jul 1;106(1):111-8. doi: 10.1002/jso.23044. Epub 2012 Feb 6.

PMID:
22311829

Supplemental Content

Loading ...
Support Center